---
name: sarscov2_vitro_touret
description: |-
    An in-vitro screen of the Prestwick chemical library composed of 1,480
    approved drugs in an infected cell-based assay.
targets:
    - id: activity_SARSCoV2
      description: whether it is active against SARSCoV2 (1) or not (0).
      units:
      type: boolean
      names:
          - noun: activity against the Corona virus
          - noun: activity against SARSCoV2
          - noun: activity against COVID19
          - adjective: active against the Corona virus
          - adjective: active against SARSCoV2
          - adjective: active against COVID19
benchmarks:
    - name: TDC
      link: https://tdcommons.ai/
      split_column: split
identifiers:
    - id: SMILES
      type: SMILES
      description: SMILES
license: CC BY 4.0
links:
    - url: https://doi.org/10.1038/s41598-020-70143-6
      description: corresponding publication
    - url: https://tdcommons.ai/single_pred_tasks/hts/#sars-cov-2-in-vitro-touret-et-al
      description: Data source
num_points: 1484
bibtex:
    - |-
      @article{Touret2020,
      doi = {10.1038/s41598-020-70143-6},
      url = {https://doi.org/10.1038/s41598-020-70143-6},
      year = {2020},
      month = aug,
      publisher = {Springer Science and Business Media LLC},
      volume = {10},
      number = {1},
      author = {Franck Touret and Magali Gilles and Karine Barral and  Antoine Nougairede
      and Jacques van Helden and Etienne Decroly and Xavier de Lamballerie and Bruno Coutard},
      title = {In vitro screening of a FDA approved chemical library reveals potential inhibitors of
      SARS-CoV-2 replication},
      journal = {Scientific Reports}
